Hoechst 33258 [23491-44-3]

Katalog-Nummer HY-15558-100mg

Size : 100mg

Marke : MedChemExpress

Weitere Informationen anfordern

Contact local distributor :


Telefonnummer : +1 850 650 7790

Beschreibung

Hoechst 33258 is a marker dye in Hoechst series. Hoechst is A live nuclear marker dye. Hoechst binds to the grooves in the DNA double strand, which tends to be A/ T-rich DNA strand. Although it binds to all nucleic acids, the A/ T-rich double strand DNA significantly enhances fluorescence intensity Therefore,Hoechst dye can be used for living cell labeling. The fluorescence intensity of Hoechst dye increases with the increase of pH of solution[1].

IC50 & Target

IC50: 51.31±4.56 μM (HeLa cell), 32.43±3.27 μM (HL60 cell), 15.42 ± 2.16 μM (U937 cell)[1]

Cellular Effect
Cell Line Type Value Description References
A2780 IC50
12 μM
Compound: HOE-33258
Antitumor activity of compound for 96-h exposure in A2780 human ovarian cell line
Antitumor activity of compound for 96-h exposure in A2780 human ovarian cell line
[PMID: 11170623]
A2780cisR IC50
9.5 μM
Compound: HOE-33258
Antitumor activity of compound for 96-h exposure in A2780cisR (acquired resistance to cisplatin) human ovarian cell line
Antitumor activity of compound for 96-h exposure in A2780cisR (acquired resistance to cisplatin) human ovarian cell line
[PMID: 11170623]
A549 IC50
≥ 31.2 μg/mL
Compound: 2
Cytotoxicity against human A549 cells assessed as reduction in cell survival after 24 hrs by resazurin assay
Cytotoxicity against human A549 cells assessed as reduction in cell survival after 24 hrs by resazurin assay
[PMID: 27301676]
AGS GI50
112 x 10-6 mol/dm3
Compound: Hoechst 33258
Cytotoxicity against human AGS cells after 72 hrs by MTT assay
Cytotoxicity against human AGS cells after 72 hrs by MTT assay
[PMID: 21227551]
BEAS-2B IC50
≥ 31.2 μg/mL
Compound: 2
Cytotoxicity against human BEAS2B cells assessed as reduction in cell survival after 24 hrs by resazurin assay
Cytotoxicity against human BEAS2B cells assessed as reduction in cell survival after 24 hrs by resazurin assay
[PMID: 27301676]
Caco-2 GI50
84 x 10-6 mol/dm3
Compound: Hoechst 33258
Cytotoxicity against human Caco2 cells after 72 hrs by MTT assay
Cytotoxicity against human Caco2 cells after 72 hrs by MTT assay
[PMID: 21227551]
CH1 IC50
26.5 μM
Compound: HOE-33258
Antitumor activity of compound for 96-h exposure in CH1 human ovarian cell line
Antitumor activity of compound for 96-h exposure in CH1 human ovarian cell line
[PMID: 11170623]
HeLa GI50
115.7 x 10-6 mol/dm3
Compound: Hoechst 33258
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
[PMID: 21227551]
HeLa IC50
51.31 μM
Compound: H. 33258, Hoechst 33258
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
[PMID: 22959518]
HEp-2 GI50
132.5 x 10-6 mol/dm3
Compound: Hoechst 33258
Cytotoxicity against human Hep2 cells after 72 hrs by MTT assay
Cytotoxicity against human Hep2 cells after 72 hrs by MTT assay
[PMID: 21227551]
HL-60 IC50
32.43 μM
Compound: H. 33258, Hoechst 33258
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
[PMID: 22959518]
MCF7 GI50
5.7 x 10-6 mol/dm3
Compound: Hoechst 33258
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
[PMID: 21227551]
MDCK GI50
157.5 x 10-6 mol/dm3
Compound: Hoechst 33258
Cytotoxicity against MDCK cells after 72 hrs by MTT assay
Cytotoxicity against MDCK cells after 72 hrs by MTT assay
[PMID: 21227551]
MIA PaCa-2 GI50
191.5 x 10-6 mol/dm3
Compound: Hoechst 33258
Cytotoxicity against human MIAPaCa2 cells after 72 hrs by MTT assay
Cytotoxicity against human MIAPaCa2 cells after 72 hrs by MTT assay
[PMID: 21227551]
NCI-H358 GI50
91.7 x 10-6 mol/dm3
Compound: Hoechst 33258
Cytotoxicity against human NCI-H358 cells after 72 hrs by MTT assay
Cytotoxicity against human NCI-H358 cells after 72 hrs by MTT assay
[PMID: 21227551]
SK-OV-3 IC50
> 100 μM
Compound: HOE-33258
Antitumor activity of compound for 96-h exposure in SKOV-3 human ovarian cell line
Antitumor activity of compound for 96-h exposure in SKOV-3 human ovarian cell line
[PMID: 11170623]
U-937 IC50
15.42 μM
Compound: H. 33258, Hoechst 33258
Cytotoxicity against human U937 cells after 72 hrs by MTT assay
Cytotoxicity against human U937 cells after 72 hrs by MTT assay
[PMID: 22959518]
In Vitro

General Protocol
Preparation of Hoechst working solution
1.1 Preparation of the stock solution
Dissolve 10 mg of in 5 mL DMSO
Note: It is recommended to store the stock solution at 4℃ or -20℃ away from light and avoid repetitive freeze-thaw cycles.
1.2 Preparation of Hoechst working solution
Dilute the stock solution in serum-free cell culture medium or PBS to obtain final concentration 10 μg/mL Hoechst working solution.
Note: Please adjust the concentration of Hoechst working solution according to the actual situation.
1.Cell staining
2.1 Suspension cells(6-well plate)
a. Centrifuge at 1000 g at 4℃ for 3-5 minutes and then discard the supernatant. Wash twice with PBS, 5 minutes each time. The cell density is 1×106/mL.
b. Add 1 mL of working solution, and then incubate at room temperature for 3-10 minutes.
c. Centrifuge at 400 g at 4℃ for 3-4 minutes and then discard the supernatant.
d. Wash twice with PBS, 5 minutes each time.
e. Resuspend cells with serum-free cell culture medium or PBS. Observation by fluorescence microscopy or flow cytometry.
2.2 Adherent cells
a. Culture adherent cells on sterile coverslips.
b. Remove the coverslip from the medium and aspirate excess medium.
c. Add 100 μL of working solution, gently shake it to completely cover the cells,and then incubate at room temperature for 3-10 minutes.
d. Wash twice with medium, 5 minutes each time.Observation by fluorescence microscopy or flow cytometry.

Precautions
1. Please adjust the concentration of Hoechst working solution according to the actual situation.
2. This product is for R&D use only, not for drug, household, or other uses.
3. For your safety and health, please wear a lab coat and disposable gloves to operate.

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Lösungsmittel & Löslichkeit
In Vitro: 

DMSO : 41.67 mg/mL (98.16 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.3557 mL 11.7786 mL 23.5571 mL
5 mM 0.4711 mL 2.3557 mL 4.7114 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.08 mg/mL (4.90 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.08 mg/mL (4.90 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Reinheit & Dokumentation
Dyeing Example
Verweise

Sie könnten auch an folgenden Produkten interessiert sein:



Katalog-Nummer
Beschreibung
Cond.
Preis zzgl. MwSt.
331-10553-1
 100mg